Evidence map›Paper›PMID 42877822›Full record

ArticlePulmonary circulation2026

Macrophages Contribute to Pulmonary Hypertension Associated With Sickle Cell Disease.

Christina Lisk, Francesca Cendali, Natalie Westover, Delaney Swindle, Daniel Colon Hidalgo, Caitlin Lewis, Melissa J Lucero, Nishant K Rana, Gemlyn George, Saini Setua and 8 more

Abstract read
In one paragraph

Article in Pulmonary circulation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Christina LiskCardiovascular and Pulmonary Research Laboratory, Department of Medicine University of Colorado Denver - Anschutz Medical Campus Aurora Colorado USA.ORCID https://orcid.org/0000-0001-6217-4063
Francesca CendaliCardiovascular and Pulmonary Research Laboratory, Department of Medicine University of Colorado Denver - Anschutz Medical Campus Aurora Colorado USA.ORCID https://orcid.org/0000-0002-8874-2150
Natalie WestoverCardiovascular and Pulmonary Research Laboratory, Department of Medicine University of Colorado Denver - Anschutz Medical Campus Aurora Colorado USA.ORCID https://orcid.org/0009-0001-5329-4554
Delaney SwindleCardiovascular and Pulmonary Research Laboratory, Department of Medicine University of Colorado Denver - Anschutz Medical Campus Aurora Colorado USA.ORCID https://orcid.org/0009-0008-5521-6518
Daniel Colon HidalgoSection of Pediatric Critical Care Medicine, Department of Pediatrics University of Colorado Denver - Anschutz Medical Campus and Children's Hospital Colorado Aurora Colorado USA.ORCID https://orcid.org/0000-0002-2385-125X
Caitlin LewisSection of Pediatric Critical Care Medicine, Department of Pediatrics University of Colorado Denver - Anschutz Medical Campus and Children's Hospital Colorado Aurora Colorado USA.ORCID https://orcid.org/0000-0002-6113-7815
Melissa J LuceroCardiovascular and Pulmonary Research Laboratory, Department of Medicine University of Colorado Denver - Anschutz Medical Campus Aurora Colorado USA.ORCID https://orcid.org/0000-0002-1619-6322
Nishant K RanaCardiovascular and Pulmonary Research Laboratory, Department of Medicine University of Colorado Denver - Anschutz Medical Campus Aurora Colorado USA.ORCID https://orcid.org/0000-0003-4255-977X
Gemlyn GeorgeDivision of Hematology Colorado Sickle Cell Treatment and Research Center, School of Medicine University of Colorado Denver - Anschutz Medical Campus Aurora Colorado USA.ORCID https://orcid.org/0000-0002-4518-0629
Saini SetuaDepartment of Pediatrics, Center for Blood Oxygen Transport University of Maryland School of Medicine Baltimore Maryland USA.ORCID https://orcid.org/0000-0002-9874-6948
Monika DzieciatkowskaDepartment of Biochemistry & Molecular Genetics, Graduate School University of Colorado, Anschutz, Medical Campus Aurora Colorado USA.
Kathryn HasselDivision of Hematology Colorado Sickle Cell Treatment and Research Center, School of Medicine University of Colorado Denver - Anschutz Medical Campus Aurora Colorado USA.ORCID https://orcid.org/0000-0003-1779-6386
Christy S NiemeyerNeurology Department, School of Medicine University of Colorado Denver - Anschutz Medical Campus Aurora Colorado USA.ORCID https://orcid.org/0000-0001-6830-6522
Kurt StenmarkCardiovascular and Pulmonary Research Laboratory, Department of Medicine University of Colorado Denver - Anschutz Medical Campus Aurora Colorado USA.ORCID https://orcid.org/0000-0001-6918-6411
Eva NozikSection of Pediatric Critical Care Medicine, Department of Pediatrics University of Colorado Denver - Anschutz Medical Campus and Children's Hospital Colorado Aurora Colorado USA.ORCID https://orcid.org/0000-0002-7229-5528
Angelo D'AlessandroDepartment of Biochemistry & Molecular Genetics, Graduate School University of Colorado, Anschutz, Medical Campus Aurora Colorado USA.ORCID https://orcid.org/0000-0002-2258-6490
Paul W BuehlerCardiovascular and Pulmonary Research Laboratory, Department of Medicine University of Colorado Denver - Anschutz Medical Campus Aurora Colorado USA.ORCID https://orcid.org/0000-0003-0687-3008
David C IrwinCardiovascular and Pulmonary Research Laboratory, Department of Medicine University of Colorado Denver - Anschutz Medical Campus Aurora Colorado USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary hypertension (PH) is a fatal sequela in sickle cell disease (SCD) patients and occurs with greater prevalence compared to the general population. Macrophages (Mϕ) are one of the first immune cells to be recruited to the lungs in mouse models of PH, including SCD-PH, and a key cell type that contribute toward disease progression. Here, we first determined if phenotypic difference exist between control (C57BL/6) and Berkeley-SS (Berk-SS, SCD) mouse pulmonary Mϕs and, if so, how chronic moderate hypoxic exposure (~8,000 ft, Pb ~568 mmHg for 10 weeks) altered molecular and metabolic pathways. Next, we aimed to determine if the microenvironment of the Berk-SS lung is primed for Mϕs recruitment compared to the C57BL/6 lung. Using precision cut lung slice (PCLS), we determined PCLS from Berk-SS mice have significant increases in adhesion molecules associate with Mϕ recruitment and recruit splenic Mϕs at a greater rate compared to control mice. We confirmed these results in an acute hypoxic exposure (18,000 ft for 3 days) experiment and our results suggest that Berk-SS mice recruit more interstitial Mϕ with a pro-inflammatory phenotype when compared to C57BL/6 mice. Lastly, the depletion of Mϕ in our Berk-SS PH model improved right ventricular function, decreased pulmonary vascular muscularization, and improved exercise tolerance. Together, these data emphasize a critical role of Mϕ pulmonary recruitment in SCD-PH pathophysiology that is driven by inflammation.

Indexed as

exercise tolerancehemodynamicshypoxiametabolomicsproteomics

Identifiers

PMID42877822
PMCPMC13666554

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.